BioNTech SE (BNTX) Enterprise Value (2018 - 2025)
BioNTech SE (BNTX) reported Enterprise Value of -$17.3 billion for Q4 2025, up 3.44% on a YoY basis from -$16.7 billion in Q4 2024, and down 1.97% sequentially from -$17.0 billion in Q3 2025.
BioNTech SE (BNTX) Enterprise Value (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Enterprise Value data on file, last reported at -$17.3 billion in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 3.44% year-over-year to -$17.3 billion; the trailing twelve-month figure through Dec 2025 stood at -$17.3 billion (up 3.44% YoY), and the FY2025 full-year result was -$16.8 billion, up 6.28% from the prior year.
- Enterprise Value declined to -$17.3 billion in Q4 2025, from -$17.0 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$432.8 million in Q3 2021 to a low of -$18.6 billion in Q2 2024.
- A 5-year average of -$11.4 billion and a median of -$15.4 billion in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value gained 15.45% in 2022 and plunged 1191.77% in 2023, its largest moves.
- Tracing BNTX's Enterprise Value over 5 years: stood at -$2.4 billion in 2021, then tumbled by 504.7% to -$14.3 billion in 2022, then declined by 24.09% to -$17.8 billion in 2023, then retreated by 0.73% to -$17.9 billion in 2024, then rose by 3.44% to -$17.3 billion in 2025.
- Business Quant data shows BNTX's Enterprise Value at -$17.3 billion in Q4 2025, -$17.0 billion in Q3 2025, and -$15.9 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | -17.32 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.32 Bn |
| Sep 30, 2025 | -16.98 Bn |
| Jun 30, 2025 | -15.89 Bn |
| Mar 31, 2025 | -14.84 Bn |
| Dec 31, 2024 | -17.93 Bn |
| Sep 30, 2024 | -18.35 Bn |
| Jun 30, 2024 | -18.63 Bn |
| Mar 31, 2024 | -17.02 Bn |
| Dec 31, 2023 | -17.81 Bn |
| Sep 30, 2023 | -17.14 Bn |
| Jun 30, 2023 | -16.94 Bn |
| Mar 31, 2023 | -13.59 Bn |
| Dec 31, 2022 | -14.35 Bn |
| Sep 30, 2022 | -1.33 Bn |
| Jun 30, 2022 | -1.49 Bn |
| Mar 31, 2022 | -1.96 Bn |
| Dec 31, 2021 | -2.37 Bn |
| Sep 30, 2021 | -432.80 Mn |
| Jun 30, 2021 | -1.76 Bn |
| Mar 31, 2021 | -1.08 Bn |